Market revenue in 2022 | USD 5.1 million |
Market revenue in 2030 | USD 15.6 million |
Growth rate | 15% (CAGR from 2022 to 2030) |
Largest segment | Stem cells |
Fastest growing segment | Other Products |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Stem cells, Other Products |
Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 52.94% in 2022. Horizon Databook has segmented the China veterinary regenerative medicine market based on stem cells, other products covering the revenue growth of each sub-segment from 2018 to 2030.
Regenerative medicine is a recent, interdisciplinary field of study, and China has rapidly made significant advancements in it, making numerous research discoveries in stem cells, tissue engineering, and active chemicals. The therapeutic potential of stem cell-based therapies in treating a wide range of illnesses and injuries with significant unmet medical needs has boosted market growth in China, where stem cell-based therapies have been actively investigated for decades.
In recent years, clinical trials of stem cell-based therapies have gained popularity in China. Chinese researchers have used pig cells to create pluripotent stem cells, which, like embryonic stem cells, can differentiate into any cell in the body. This was accomplished for the first time using somatic cells (cells other than sperm or egg cells) from any ruminant animal (known as ungulates).
The findings can lead the way for generating pigs resistant to diseases like swine flu, developing models for human genetic diseases, and genetically engineering animals for human organ transplant.
Horizon Databook provides a detailed overview of country-level data and insights on the China veterinary regenerative medicine market , including forecasts for subscribers. This country databook contains high-level insights into China veterinary regenerative medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account